Search results
FATE To End Janssen Deal and Prioritize Pipeline Development
Zacks via Yahoo Finance· 1 year agoFate Therapeutics, Inc. FATE announced that it has declined a proposal from Janssen Biotech, Inc., a...
Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients
Benzinga via Yahoo Finance· 2 years agoJanssen Biotech Inc, a Johnson & Johnson (NYSE: JNJ) unit, received European conditional approval...
Biotech Stock Roundup: BMY's Study Update, INCY's Drug Label Expansion, MRNA News
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory updates are in focus in the biotech sector. COVID-19 vaccine...
Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in...
Benzinga via Yahoo Finance· 11 months agoProtagonist Therapeutics (NASDAQ: PTGX) reported data from its collaboration with Janssen Biotech...
Protagonist (PTGX) Up on Positive Results From FRONTIER Study
Zacks via Yahoo Finance· 1 year agoShares of Protagonist Therapeutics, Inc. PTGX surged 51.91% on Mar 7 after the company announced...
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in the spotlight this week courtesy of acquisition news and strategic...
Aligos Co-Founders File Complaint Against Johnson & Johnson Alleging Fraud
Benzinga via Yahoo Finance· 2 years agoAligos Therapeutics Inc (NASDAQ: ALGS) has filed a response to the complaint of and counterclaims...
Why Protagonist Therapeutics Shares Are Trading Higher Today
Benzinga via Yahoo Finance· 1 year agoProtagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from its collaboration with...
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...
4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates
Zacks via Yahoo Finance· 6 months agoAs we near the end of the ongoing earnings season, the scorecard for the Medical sector appears...